A BIOFUNCTIONAL THEORY OF RELIGIONGALLUS A.CURRENT ANTHROPOLOGY. 1972, Vol 13, Num 5, pp 543-568Article

A BIOFUNCTIONAL THEORY OF RELIGIONGALLUS A.CURRENT ANTHROPOLOGY. 1972, Vol 13, Num 5, pp 543-568Article

DU GALLUS'S BIOFUNCTIONAL THEORY OF RELIGIONKRYVELEV I. A; GALLUS A.CURRENT ANTHROPOLOGY. 1974, Vol 15, Num 1, pp 92-99Article

Excavations at Keilor, Victoria. Report N 3. Excavation in the D ClayGALLUS, A.Artefact (The) Melbourne. 1983, Vol 8, Num 1-2, pp 11-41Article

Anticoagulants in the prevention of venous thromboembolismGALLUS, A. S.Baillière's clinical haematology. 1990, Vol 3, Num 3, pp 651-684, issn 0950-3536, 34 p.Article

Indications for oral anticoagulant treatmentGALLUS, A. S.Drugs (Basel). 1983, Vol 26, Num 6, pp 543-549, issn 0012-6667Article

Warfarin : is it time to reduce target ranges again ?SAOUR, J; GALLUS, A.Australian and New Zealand journal of medicine. 1993, Vol 23, Num 6, pp 692-696, issn 0004-8291Conference Paper

Focal glomerulosclerosis treated with heparinLINES, D. R; COLEMAN, M; GALLUS, A et al.Archives of disease in childhood. 1989, Vol 64, Num 6, pp 855-857, issn 0003-9888, 3 p.Article

Orgaran (Org 10172) or heparin for preventing venous thrombosis after elective surgery for malignant disease ? A double-blind, randomised multicentre comparisonGALLUS, A; CADE, J; OCKELFORD, P et al.Thrombosis and haemostasis. 1993, Vol 70, Num 4, pp 562-567, issn 0340-6245Article

Prevention of venous thrombosis with minidose warfarin after joint replacementDALE, C; GALLUS, A; WYCHERLEY, A et al.BMJ. British medical journal (International ed.). 1991, Vol 303, Num 6796, issn 0959-8146, p. 224Article

The influence of Org 10172, an antithrombotic heparinoid, on urinary blood loss after transurethral prostatectomyGALLUS, A; MURPHY, W; NACEY, J et al.Thrombosis research. 1989, Vol 56, Num 2, pp 229-238, issn 0049-3848, 10 p.Article

Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolismGALLUS, A; JACKAMAN, J; TILLETT, J et al.Lancet (British edition). 1986, Num 8519, pp 1293-1296, issn 0140-6736Article

Applying risk assessment models in orthopaedic surgery : overview of our clinical experienceGALLUS, A. S.Blood coagulation & fibrinolysis. 1999, Vol 10, pp S53-S61, issn 0957-5235, SUP2Conference Paper

Thrombolytic therapy for venous thrombosis and pulmonary embolismGALLUS, A. S.Baillière's clinical haematology. 1998, Vol 11, Num 3, pp 663-673, issn 0950-3536Article

Sera from patients with systemic lupus erythematosus demonstrate enhanced IgG binding to endothelial cells pretreated with tumour necrosis factor alphaQUADROS, N. P; ROBERTS-THOMSON, P. J; GALLUS, A. S et al.Rheumatology international (Berlin. Print). 1995, Vol 15, Num 3, pp 99-105, issn 0172-8172Article

Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgeryAGNELLI, G; BERGQVIST, D; COHEN, A. T et al.British journal of surgery. 2005, Vol 92, Num 10, pp 1212-1220, issn 0007-1323, 9 p.Article

Apparent lack of synergism between heparin and dihydroergotamine in prevention of deep vein thrombosis after elective hip replacement : a randomised double-blind trial reported in conjunction with an overview of previous resultsGALLUS, A. S; CADE, J. F; MILLS, K. W et al.Thrombosis and haemostasis. 1992, Vol 68, Num 3, pp 238-244, issn 0340-6245, 5 p.Article

Oral contraceptives and surgery: reduced antithrombin and antifactor XA levels without postoperative venous thrombosis in low-risk patientsGALLUS, A. S; CHOOI, C. C; KONETSCHNIK, F et al.Thrombosis research. 1984, Vol 35, Num 5, pp 513-526, issn 0049-3848Article

Thrombokinetics in patients with rheumatoid arthritis treated with D-penicillamineTHOMAS, D; GALLUS, A. S; BROOKS, P. M et al.Annals of the rheumatic diseases. 1984, Vol 43, Num 3, pp 402-406, issn 0003-4967Article

Consensus guidelines for warfarin therapy: Recommendations from the Australasian Society of Thrombosis and HaemostasisGALLUS, A. S; BAKER, R. I; CHONG, B. H et al.Medical journal of Australia. 2000, Vol 172, Num 12, pp 600-605, issn 0025-729XArticle

Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172CHONG, B. H; FAWAZ ISMAIL; CADE, J et al.Blood. 1989, Vol 73, Num 6, pp 1592-1596, issn 0006-4971Article

Prospective evaluation of a flexible protocol for starting treatment with warfarin and predicting its maintenance doseCOSH, D. G; MORITZ, C. K; ASHMAN, K. J et al.Australian and New Zealand journal of medicine. 1989, Vol 19, Num 3, pp 191-197, issn 0004-8291, 7 p.Article

Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis : An economic evaluationVAN DEN BELT, A. G. M; BOSSUYT, P. M. M; PRINS, M. H et al.Thrombosis and haemostasis. 1998, Vol 79, Num 2, pp 259-263, issn 0340-6245Article

Workshop I : The potential role of new therapies in deep vein thrombosis prophylaxisCOHEN, A. T; GALLUS, A. S; HAAS, S et al.Blood coagulation & fibrinolysis. 1999, Vol 10, pp S99-S102, issn 0957-5235, SUP2Conference Paper

Prospective randomised open-iabel comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopaenia with thrombosis : A clinical outcome studyCHONG, B. H; GALLUS, A. S; SESHADRI, P et al.Thrombosis and haemostasis. 2001, Vol 86, Num 5, pp 1170-1175, issn 0340-6245Article